Section 26B-3-137 - Reimbursement for diabetes prevention program(1) As used in this section, "DPP" means the National Diabetes Prevention Program developed by the United States Centers for Disease Control and Prevention.(2) Beginning July 1, 2022, the Medicaid program shall reimburse a provider for an enrollee's participation in the DPP if the enrollee:(a) meets the DPP's eligibility requirements; and(b) has not previously participated in the DPP after July 1, 2022, while enrolled in the Medicaid program.(3) Subject to appropriation, the Medicaid program may set the rate for reimbursement.(4) The department may apply for a state plan amendment if necessary to implement this section.(5)(a) On or after July 1, 2025, but before October 1, 2025, the department shall provide a written report regarding the efficacy of the DPP and reimbursement under this section to the Health and Human Services Interim Committee.(b) The report described in Subsection (5)(a) shall include:(i) the total number of enrollees with a prediabetic condition as of July 1, 2022;(ii) the total number of enrollees as of July 1, 2022, with a diagnosis of type 2 diabetes;(iii) the total number of enrollees who participated in the DPP;(iv) the total cost incurred by the state to implement this section; and(v) any conclusions that can be drawn regarding the impact of the DPP on the rate of type 2 diabetes for enrollees.Renumbered from § 26-18-28 and amended by Chapter 306, 2023 General Session ,§ 37, eff. 5/3/2023.Added by Chapter 206, 2022 General Session ,§ 1, eff. 5/4/2022.